beta thalassemia
Showing 1 - 12 of 12
Luspatercept in Korean Myelodysplastic Syndrome or ß-thalassemia
Not yet recruiting
- Myelodysplastic Syndrome
- Beta Thalassemia
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)
Recruiting
- Sickle Cell Anemia
- Beta Thalassemia
- TBI
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)
Active, not recruiting
- Sickle Cell Disease
- Beta Thalassemia
- Busulfan
- +3 more
-
New York, New YorkMorgan Stanley Children's Hospital, New York-Presbyterian, Colum
Aug 12, 2021
Heart Status in Patients of Beta Thalassemia Using
Recruiting
- Beta Thalassemia
- Echocardiogram and Hematological Analysis
-
Guangzhou, Guangdong, ChinaSouthern Medical University
Jun 16, 2021
Clinical Severity of Beta Thalassemia
Recruiting
- Beta Thalassemia
- Hematological Phenotype Analysis
-
Guangzhou, Guangdong, ChinaSouthern Medical University
Jun 8, 2021
Genetic Variants Affecting Clinical Severity of Beta Thalassemia
Recruiting
- Beta Thalassemia
- Hematological Analysis and Genetical Analysis
-
Guangzhou, Guangdong, ChinaSouthern Medical University
Jun 8, 2021
Beta Thalassemia Trial in Tanta (spirulina)
Completed
- Beta Thalassemia
- spirulina
-
Tanta, Gharbia, EgyptFaculty of Medicine- Tanta University
Sep 10, 2018
Leukemia, Lymphoma, Bone Marrow Failure Trial in Valhalla (Full Intensity with TBI, Full Intensity, Reduced Intensity)
Completed
- Leukemia
- +7 more
- Full Intensity with TBI
- +3 more
-
Valhalla, New YorkNew York Medical College
Aug 20, 2018
Genetic Factors Affecting the Severity of Beta Thalassemia
Completed
- Beta Thalassemia
-
Jerusalem, IsraelHadassah Medical Organization
Aug 9, 2017
Beta Thalassemia, Hemoglobinopathy Trial run by the NIDDK (Hydroxyurea)
Completed
- Beta Thalassemia
- Hemoglobinopathy
-
Bethesda, MarylandNational Institute of Diabetes and Digestive and Kidney Diseases
Mar 3, 2008
Beta Thalassemia Trial run by the NIDDK (5-Azacytidine)
Completed
- Beta Thalassemia
-
Bethesda, MarylandNational Institute of Diabetes and Digestive and Kidney Diseases
Mar 3, 2008